Drug intelligence / Profile preview

Vinsalpium

Development stage
Unknown
Lead developer
Vinh Phuc Pharmaceutical
Modality
Small Molecules
Administration
Inhalation
01

Overview

**Vinsalpium** is a Vietnamese fixed-dose nebulizer solution containing the short-acting beta-2 adrenergic agonist salbutamol and the short-acting antimuscarinic bronchodilator ipratropium bromide. Salbutamol relaxes bronchial smooth muscle through beta-2 adrenergic receptor activation, while ipratropium blocks muscarinic receptor-mediated vagal bronchoconstriction. The product is indicated for reversible bronchospasm associated with obstructive airway disease and has been evaluated in chronic obstructive pulmonary disease, where it showed efficacy and safety comparable with Combivent. ([bvthongnhatdn.vn](https://bvthongnhatdn.vn/filedulieu/duoc/vinsalpium.pdf))

Brand names
Vinsalpium
Other names
ipratropium bromide + salbutamolipratropium bromide + salbutamol sulfate
02

Targets

CHRM2 (M2)CHRM3 (M3)M1 (Muscarinic acetylcholine receptor M1)ADRB2 (β2)

Beyond the preview

Go deeper on Vinsalpium.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Vinsalpium.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call